1. |
邹文斌, 李兆申. 中国胃癌发病率及死亡率研究进展. 中国实用内科杂志, 2014, 34(4): 408-413.
|
2. |
Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J, 1998, 12(12): 1063-1073.
|
3. |
Pang LY, Hurst EA, Argyle DJ. Cyclooxygenase-2: a role in cancer stem cell survival and repopulation of cancer cells during therapy. Stem Cells Int, 2016, 2016: 2048731.
|
4. |
Yun CT, Yu HT, Min JT, et al. Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog, 2012, 51(12): 939-951.
|
5. |
Wells GA, Shea B, O’connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomized studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
|
6. |
丁涤非, 胡凯, 方萍. 胃癌组织中COX-2与PTEN的表达及临床病理的关系. 淮海医药, 2015, 33(5): 417-419.
|
7. |
Yu JR, Wu YJ, Qin Q, et al. Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis. Word J Gastroenterol, 2005, 11(31): 4908-4911.
|
8. |
Joo YE, Chung LJ, Park YK, et al. Expression of Cyclooxygenase-2, p53 and Ki-67 in Gastric Cancer. J Korean Med Sci, 2006, 21(5): 871-876.
|
9. |
Okano H, Shinohara H, Miyamoto A, et al. Concomitant overexpression of cyclooxygenase-2 in her-2-positive on smad4-reduced human gastric carcinomas is associated with a poor patient outcome. Clin Cancer Res, 2004, 21(8): 6938-6945.
|
10. |
Sonoda R, Naomoto Y, Shirakawa, et al. Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett’s oesophagus and intestinal-type gastric carcinoma. Histopathology, 2010, 57(1): 90-100.
|
11. |
Uefuji K, Ichikura T, Mochizuki H. Increased expression of interleukin-1α and cyclooxygenase-2 in human gastric cancer: a possible role in tumor progression. Anticancer Res, 2005, 25(5): 3225-3230.
|
12. |
Rehab M, Asmaa G, Moshira M, et al. Cyclooxygenase-2 expression in chronic gastritis and gastric carcinoma, correlation with prognostic parameters. J Egypt Natl Canc Inst, 2006, 18(4): 363-374.
|
13. |
朱艳丽, 刘亮, 张天英. COX-2和C-MYC在胃癌发生发展中的表达及其相关性研究. 黑龙江医药科学, 2016, 39(5): 28-31.
|
14. |
Salem MN, Elghany MEA, Lashin HE, et al. Expression of COX 2 in gastric mucosa of patients with gastric carcinoma and its correlation with the disease progression. J Am Sci, 2014, 10(9): 218-224.
|
15. |
翟俊山, 李楠, 宋久刚. 胃癌组织中APPL1和COX-2的表达及其与患者预后的关系. 胃肠病学和肝病学杂志, 2016, 25(1): 16-19.
|
16. |
Park ES, Do IG, Park CK, et al. Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection. Clin Cancer Res, 2009, 15(1): 291-298.
|
17. |
李红刚, 喻伦银, 刘铭球. 环氧化酶-2与肿瘤. 国外医学肿瘤学分册, 2001, 28(6). 420-423.
|
18. |
Akhtar M, Cheng Y, Magno RM, et al. Promoter methylation regulates helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res, 2001, 61(6): 2399-2401.
|
19. |
Saukkonen K, Buskens CJ, Sivula A, et al. COX-2 in cancer. Milestones in Drug Therapy, 2004, 11(3): 227-243.
|
20. |
Khan Z, Khan N, Tiwari RP, et al. Biology of Cox-2: an application in cancer therapeutics. Curr Drug Targets, 2011, 12(7): 1082-1093.
|
21. |
Nunez F, Bravo S, Cruzat F, et al. Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. Plos One, 2011, 6(4): 1-10.
|
22. |
Tsujii M, Kwawano S, Tsujis, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 1998, 93(5): 705-716.
|
23. |
Yanislav K, Hiroyuki U, Satoru I, et al. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann Surg Oncol, 2007, 14(10): 2738-2747.
|
24. |
Robert A, Soslow MD, Andrew J, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer, 2000, 89(12): 2637-2645.
|
25. |
Singh B, Berry JA, Shoher A, et al. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol, 2005, 26(5): 1393-1399.
|
26. |
Yan WF, Sun PC, Nie CF, et al. Cyclooxygenase-2 polymorphisms were associated with the risk of gastric cancer: evidence from a meta-analysis based on case-control studies. Tumour Biol, 2013, 34(6): 3323-3330.
|
27. |
伊正辉. 胃癌组织中COX-2表达的Meta分析. 中国肿瘤, 2007, 16(5): 365-367.
|
28. |
曾金燕. 胃癌组织中COX-2的表达及其与淋巴结转移相关性的Meta分析. 肿瘤防治研究, 2011, 38(5): 584-587.
|
29. |
Hsu KW, Hsieh RH, Wu CW, et al. MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2. Mol Biol Cell, 2009, 20(24): 5127-5137.
|
30. |
Yao LP, Liu F, Liu H, et al. The function and mechanism of COX-2 in angiogenesis of gastric cancer cells. J Exp Clin Cancer, 2011, 30(13): 1-5.
|